FINE FOODS & PHARMACEUTICALS (FF.MI) Stock Fundamental Analysis
BIT:FF - IT0005215329 - Common Stock
8.94 EUR
+0.28 (+3.23%)
Overall FF gets a fundamental rating of 5 out of 10. We evaluated FF against 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of FF get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on FF.
1. Profitability
1.1 Basic Checks
FF had positive earnings in the past year.
FF had a positive operating cash flow in the past year.
In multiple years FF reported negative net income over the last 5 years.
FF had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of FF (5.41%) is better than 72.22% of its industry peers.
FF has a Return On Equity of 9.93%. This is in the better half of the industry: FF outperforms 72.22% of its industry peers.
FF's Return On Invested Capital of 9.48% is fine compared to the rest of the industry. FF outperforms 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FF is below the industry average of 7.14%.
The 3 year average ROIC (3.16%) for FF is below the current ROIC(9.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.93% | ||
| ROIC | 9.48% |
ROA(3y)-0.42%
ROA(5y)0.94%
ROE(3y)-1.24%
ROE(5y)0.96%
ROIC(3y)3.16%
ROIC(5y)3.16%
1.3 Margins
Looking at the Profit Margin, with a value of 3.61%, FF is doing worse than 66.67% of the companies in the same industry.
With a Operating Margin value of 6.50%, FF is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
FF's Operating Margin has improved in the last couple of years.
FF has a Gross Margin of 32.54%. This is in the lower half of the industry: FF underperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of FF has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.5% | ||
| PM (TTM) | 3.61% | ||
| GM | 32.54% |
OM growth 3Y24.97%
OM growth 5Y2.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.32%
GM growth 5Y2.27%
2. Health
2.1 Basic Checks
FF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for FF remains at a similar level compared to 1 year ago.
The number of shares outstanding for FF has been increased compared to 5 years ago.
Compared to 1 year ago, FF has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.18 indicates that FF is not in any danger for bankruptcy at the moment.
FF has a Altman-Z score (3.18) which is comparable to the rest of the industry.
FF has a debt to FCF ratio of 4.90. This is a neutral value as FF would need 4.90 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.90, FF is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
FF has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
FF's Debt to Equity ratio of 0.27 is fine compared to the rest of the industry. FF outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 4.9 | ||
| Altman-Z | 3.18 |
ROIC/WACC1.18
WACC8.03%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FF should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.36, FF is doing worse than 72.22% of the companies in the same industry.
FF has a Quick Ratio of 1.36. This is a bad value and indicates that FF is not financially healthy enough and could expect problems in meeting its short term obligations.
FF has a worse Quick ratio (0.91) than 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1893.44% over the past year.
The Revenue has decreased by -3.85% in the past year.
Measured over the past years, FF shows a quite strong growth in Revenue. The Revenue has been growing by 8.83% on average per year.
EPS 1Y (TTM)1893.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.26%
Revenue 1Y (TTM)-3.85%
Revenue growth 3Y7.75%
Revenue growth 5Y8.83%
Sales Q2Q%-3.92%
3.2 Future
Based on estimates for the next years, FF will show a very strong growth in Earnings Per Share. The EPS will grow by 26.41% on average per year.
FF is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.10% yearly.
EPS Next Y34.7%
EPS Next 2Y31.28%
EPS Next 3Y27.46%
EPS Next 5Y26.41%
Revenue Next Year6.76%
Revenue Next 2Y10.32%
Revenue Next 3Y10.11%
Revenue Next 5Y12.1%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.15 indicates a correct valuation of FF.
Compared to the rest of the industry, the Price/Earnings ratio of FF indicates a rather cheap valuation: FF is cheaper than 94.44% of the companies listed in the same industry.
FF is valuated cheaply when we compare the Price/Earnings ratio to 27.44, which is the current average of the S&P500 Index.
FF is valuated correctly with a Price/Forward Earnings ratio of 13.74.
94.44% of the companies in the same industry are more expensive than FF, based on the Price/Forward Earnings ratio.
FF's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.15 | ||
| Fwd PE | 13.74 |
4.2 Price Multiples
FF's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FF is cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FF indicates a somewhat cheap valuation: FF is cheaper than 77.78% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.73 | ||
| EV/EBITDA | 5.8 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FF's earnings are expected to grow with 27.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y31.28%
EPS Next 3Y27.46%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.62%, FF has a reasonable but not impressive dividend return.
FF's Dividend Yield is rather good when compared to the industry average which is at 0.73. FF pays more dividend than 94.44% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.45, FF is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.62% |
5.2 History
The dividend of FF has a limited annual growth rate of 4.24%.
Dividend Growth(5Y)4.24%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
FF pays out 22.40% of its income as dividend. This is a sustainable payout ratio.
FF's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.4%
EPS Next 2Y31.28%
EPS Next 3Y27.46%
BIT:FF (9/11/2025, 7:00:00 PM)
8.94
+0.28 (+3.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners12.52%
Inst Owner ChangeN/A
Ins Owners53.17%
Ins Owner ChangeN/A
Market Cap197.22M
Analysts85.45
Price Target12.31 (37.7%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.62% |
Yearly Dividend0.12
Dividend Growth(5Y)4.24%
DP22.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.26%
PT rev (3m)2.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.06%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.06%
Revenue NY rev (3m)-2.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.15 | ||
| Fwd PE | 13.74 | ||
| P/S | 0.54 | ||
| P/FCF | 17.73 | ||
| P/OCF | 4.3 | ||
| P/B | 1.49 | ||
| P/tB | 1.66 | ||
| EV/EBITDA | 5.8 |
EPS(TTM)0.68
EY7.61%
EPS(NY)0.65
Fwd EY7.28%
FCF(TTM)0.5
FCFY5.64%
OCF(TTM)2.08
OCFY23.25%
SpS16.49
BVpS5.99
TBVpS5.39
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.93% | ||
| ROCE | 13.75% | ||
| ROIC | 9.48% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 11.67% | ||
| OM | 6.5% | ||
| PM (TTM) | 3.61% | ||
| GM | 32.54% | ||
| FCFM | 3.06% |
ROA(3y)-0.42%
ROA(5y)0.94%
ROE(3y)-1.24%
ROE(5y)0.96%
ROIC(3y)3.16%
ROIC(5y)3.16%
ROICexc(3y)3.64%
ROICexc(5y)4.57%
ROICexgc(3y)4.02%
ROICexgc(5y)5.02%
ROCE(3y)4.59%
ROCE(5y)4.62%
ROICexcg growth 3Y13.05%
ROICexcg growth 5Y-1.19%
ROICexc growth 3Y17.44%
ROICexc growth 5Y-2.63%
OM growth 3Y24.97%
OM growth 5Y2.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.32%
GM growth 5Y2.27%
F-Score7
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 4.9 | ||
| Debt/EBITDA | 0.91 | ||
| Cap/Depr | 220.17% | ||
| Cap/Sales | 9.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 116.33% | ||
| Profit Quality | 84.79% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 3.18 |
F-Score7
WACC8.03%
ROIC/WACC1.18
Cap/Depr(3y)145.26%
Cap/Depr(5y)138.08%
Cap/Sales(3y)9.82%
Cap/Sales(5y)9.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1893.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.26%
EPS Next Y34.7%
EPS Next 2Y31.28%
EPS Next 3Y27.46%
EPS Next 5Y26.41%
Revenue 1Y (TTM)-3.85%
Revenue growth 3Y7.75%
Revenue growth 5Y8.83%
Sales Q2Q%-3.92%
Revenue Next Year6.76%
Revenue Next 2Y10.32%
Revenue Next 3Y10.11%
Revenue Next 5Y12.1%
EBIT growth 1Y87.96%
EBIT growth 3Y34.65%
EBIT growth 5Y11.14%
EBIT Next Year138.65%
EBIT Next 3Y47.33%
EBIT Next 5Y31.96%
FCF growth 1Y3472.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.33%
OCF growth 3YN/A
OCF growth 5Y19.07%